ArticleLeukemia2025

Gemtuzumab ozogamicin in first-line treatment of CBF-AML: insights from a retrospective multi-center analysis.

Julian Ronnacker et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.